Home – English

One of most critical situations related to the COVID-10 emergency is taking place in nursing homes for elderly people. Managing the health of the elderly as well as their healthcare personnel has become a critical task, as these nursing homes are one of the epidemic’s biggest hotspots.  

The implementation of coVIDApp+ allows easy and real-time access to key information essential to provide comprehensive healthcare monitoring services, detecting new suspected cases, isolated users, professionals under study, patients with acute pathology or those requiring end-of-life care, etc. It works by means of alarms, which are activated when a healthcare response is required, indicating, for example, when a patient needs to be seen because their situation is worsening or when it should be considered to activate testing for a suspected new case of the SARS coronavirus.

In a context in which healthcare services are saturated and the pandemic originated by Covid-19 spreads rapidly, a crucial objective is to improve the management of care provided to patients in the Home Hospitalisation Unit and to minimise contact with others to avoid possible infections. 

coVIDApp+ ensures that patients are permanently connected, reporting their health status in real time from their smartphone. Thanks to the proactive monitoring, swift action can be taken on cases that may present worsening symptoms, thus optimising patient care and the use of resources. 

Patients can communicate directly with their doctor or primary healthcare team through a videocall or instant messaging, in addition to receiving information of interest according to their pre-validated condition.

The Hospital Germans Trias i Pujol, with the collaboration of the FLS Foundation for Fighting AIDS, Infectious Diseases and Promoting Health and Science, is launching a study to assess whether the administration of hydroxychloroquine to healthcare professionals continuously exposed to positive SARS-CoV-2 cases can prevent them from becoming infected or decrease the duration and severity of the infection.

Professionals who meet the criteria to participate in the study will receive the hydroxychloroquine treatment if they so choose or will be monitored should they decide they not to take it.

The follow-up with be managed with coVIDApp+, allowing for the overseeing of medication adherence, continuous monitoring of participants’ evolution and symptoms, as well as the use of anonymised data in order to draw conclusions from the study and to help extend the conclusions to the rest of the community.

Click on this link for more information about Covidapp Companies